Tag: Mabs

Over the past several decades, monoclonal antibody (mAb) therapies have fundamentally transformed the landscape of medical treatment, particularly within oncology. A common use of monoclonal antibodies in medicine is as a highly targeted therapy for certain types of cancer and autoimmune diseases by precisely targeting specific molecules.

Monoclonal antibodies (mAbs) are a cornerstone of modern medicine, with dozens of approved therapies available to treat a wide array of conditions, from autoimmune diseases to various cancers. At a functional level, these specialized, lab-made proteins are most often categorized into three main groups, which helps clarify what are the three monoclonal antibodies in a therapeutic context.

The global market for monoclonal antibody therapies was valued at over $200 billion in 2022, signaling a transformative shift in medicine. These lab-engineered proteins, often called mAbs, provide highly targeted treatments for a vast range of conditions, leaving many to ask: what does mAbs help with?